Copyright: ©Author(s) 2026.
World J Transplant. Sep 18, 2026; 16(3): 122256
Published online Sep 18, 2026. doi: 10.5500/wjt.122256
Published online Sep 18, 2026. doi: 10.5500/wjt.122256
Table 1 Evaluation protocol for potential donors in the living donor liver transplantation program at Universiti Malaya Medical Centre[4]
| Phase | Evaluation |
| 1 | Clinical evaluation: Detailed history (including alcohol consumption) and physical examination. Anthropometric measurements: Height, weight and BMI. Laboratory tests: Blood group, complete blood count, biochemical profile, coagulation profile, FLP, FBS, TFT, ANA, ASMA, caeruloplasmin, tumor markers [AFP, CEA, PSA (male > 50 years), CA 15-3 (female > 40 years)], viral serology (HBsAg, anti-HBs, anti-HBc IgG, anti-HCV, HIV Ag/Ab, VZV IgG, CMV IgG), VDRL test, urine analysis, UPT (for females), FOBT Fibroscan®: CAP and TE |
| 2 | Multiphasic CT of the liver: Including volumetry measurements of right and left lobes and liver attenuation, with or without CT of the thorax, abdomen, and pelvis. Cardiac assessment: ECG, echocardiography, with or without EST. Pulmonary assessment: CXR, pulmonary function test. Mammography: Females > 40 years of age |
| 3 | Psychological assessment, with or without liver biopsy. Informed consent |
- Citation: Lee YS, Cheng SY, Hannis A, Mahadeva S, Chew KS, Koh PS. Living donor outcomes in an emerging living donor liver transplantation program: A single-center experience from Malaysia. World J Transplant 2026; 16(3): 122256
- URL: https://www.wjgnet.com/2220-3230/full/v16/i3/122256.htm
- DOI: https://dx.doi.org/10.5500/wjt.122256